News
KEYNOTE-010 Published in The Lancet and to be Presented at the European Society for Medical Oncology (ESMO) Asia 2015 Congress...
Read moreDaktari Diagnostics today announced a collaboration with Merck, known as MSD outside the United States and Canada, to develop Daktari’s...
Read moreFirst Product from Global Partnership to Deliver High-Quality Biosimilars to Help Meet Needs of Patients and Healthcare Systems Worldwide Merck...
Read moreInternational Institute for Integrative Sleep Medicine, University of Tsukuba (“WPI-IIIS”) today announced a research collaboration agreement with Merck & Co.,...
Read moreProteros to receive upfront and research funding plus milestone payments of up to $126 million plus royalties Proteros biostructures GmbH...
Read moreMerck & Co., Inc. to make US$9 million investment in Bionomics Bionomics Limited (ASX:BNO, OTCQX:BNOEF), a biopharmaceutical company focused on...
Read morePivotal study to evaluate Incyte’s IDO1 inhibitor in combination with Merck’s anti-PD-1 therapy in patients with advanced or metastatic melanoma...
Read moreClinical trial to evaluate MacroGenics' Fc-optimized anti-HER2 antibody with Merck's anti-PD-1 therapy in patients with advanced HER2-positive gastric cancer MacroGenics,...
Read moreIngelheim, 16 November 2015 - Boehringer Ingelheim has been named one of the most innovative companies worldwide in 2015. For...
Read moreFollowing the successful closure of the merger with drug maker Ranbaxy, Dilip Shanghvi-led Sun Pharma said on Wednesday that it...
Read more
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.